The mean levels of adherence and factors contributing to non-adherence in patients on Highly Active Antiretroviral Therapy

Abstract

Objective:To determine the mean level of adherence and factors contributing to non-adherence in patients on Highly Active Antiretroviral Therapy (HAART). Methods: An observational study was done on 101 HIV/AIDS patients attending the Centre for HIV/ AIDS Research, Education and Services (CHARES) -University Hospital of the West Indies, between May 2006 and August 2006. A questionnaire was administered asking questions re: prescribed and actual dosing frequency and number of antiretroviral tablets for the previous week, reasons for nonadherence, duration of Highly Active Antiretroviral Therapy, age, employment status and level of education. Mean levels of adherence were calculated using self and social worker/nurse reported dosing frequency and number of tablets. Good adherence was defined as 95% or greater. Multiple regression analysis was used to determine factors impacting on adherence. Results: Ninety-six patients were included for final analysis. Mean levels of adherence were as follows: 87.66% -self-report for tablets; 88.70% -self-report for dosing frequency; 87.02% -social worker/ nurse report for tablets; 88.10% -social worker/nurse report for dosing frequency. There were significant positive correlations between self and social worker/nurse reports using dosing frequency (Spearman Rho correlation coefficient 0.943, p = 0.01) or number of tablets (Spearman Rho correlation coefficient 0.955, p = 0.01). Adherence to self-reported number of tablets and dosing frequency were 58.4% and 56.4% respectively. Duration of HAART was found to have a significant negative correlation with the level of self-reported adherence to tablets (p = 0.002). Conclusion: Adherence to HAART is sub-optimum in patients at the CHARES. This must be urgently addressed to prevent the development of resistant HIV strains and treatment failure.

Antiretroviral Treatment and Follow-up of HIV-Infected Patients by Health Care Providers in South African Public Primary Health Care

“…Several recent studies have reported average adherence rates to ART up to 80% to 90% of prescribed doses (Etard et al, 2007;Vriesendorp et al, 2007;Williams, Clarke, Williams, & Barton, 2007) as compared with the average of 50% to other chronic medication (Altice & Friedland, 1998;Stone, 2001). The current study reported that pill count was the most commonly used method to measure treatment adherence.…”

Adherence to Disease-Modifying Drugs in Patients with Multiple Sclerosis: A Consensus Statement from the Middle East MS Advisory Group

“…It is well known that adherence to therapies is poor in generally nonsymptomatic conditions, such as hypertension (33%-84% nonadherence; Conlin et al, 2001) and type 2 diabetes (36%-87% nonadherence; Lee et al, 2006). Moreover, patient adherence is often low even in lifethreatening conditions such as cancer (20%-100% nonadherence to oral treatments; Partridge et al, 2002) and HIV/AIDS (70%-80% nonadherence to highly active antiretroviral therapy; Williams et al, 2007).…”

Will New Injection Devices for Interferon Beta-1a s.c. Affect Treatment Adherence in Patients With Multiple Sclerosis? An Expert Opinion in the Middle East

“…For example in "silent" disorders such as hypertension adherence is reported to be only between 16% and 66% (Conlin, Gerth, Fox, Roehm, & Boccuzzi, 2001); even in symptomatic and life-threatening conditions such as cancer and HIV, treatment adherence is reported to be equally low in some cases (e.g., as low as 20% to oral neoplastic agents) (Partridge, Avorn, Wang, & Winer, 2002;Williams, Clarke, Williams, & Barton, 2007).…”